Acute Graft-versus-Host Disease Market is Estimated to Witness High Growth Owing to MaaT Pharma's Microbiome Therapeutic Approach
Acute Graft-versus-Host Disease Market is Estimated to Witness High Growth Owing to MaaT Pharma's Microbiome Therapeutic ApproachThe acute graft-versus-host disease (GVHD) market comprises therapies and prophylaxis used to treat complications arising during hematopoietic cell transplantation. Acute GVHD occurs when the donated (graft) cells view the recipient's (host) cells as foreign and...
0 Comments 0 Shares 145 Views 0 Reviews
Sponsored